A little about ourselves
Our keywords: #medical device, #radiation free, #osteoporosis
Echolight SpA, incorporated in 2010 by the founding team as a spin-off of the National Council of Research of Italy, is a med-tech company developing the very first radiation free solution for the early diagnosis of osteoporosis.
Echolight SpA secured all the standard certifications: UNI CEI EN ISO 13485: 2012, ISO 13485: 2003, UNI EN ISO 9001: 2008 Quality Management System, CE mark, FDA 510K pending, and it will be the new worldwide benchmark for the medical community focusing its growth in the development of advanced and easy to use technologies for primary care procedures.
Osteoporosis is a silent and epidemic disease that affects 200M women worldwide and the expected change in demography will worsen the issue. The alarming rise of Osteoporosis, inserted in the top 10 health priorities for the next years by WHO, has propelled the need of early detection of the disease.
Echolight proposes REMS (Radiofrequency Echographic Multi Spectrometry) a breakthrough radiation-free technology for vertebral and femural neck bone characterization totally redefining the managing of the osteoporosis disease.
The patented method is an innovative approach assessing bone micro-architecture and going beyond the commonly radiation based and ultrasound used techniques for the diagnosis of osteoporosis.
The comprehensive non-invasive solution will completely change the way to manage any osteoporosis diagnosis getting to be the first radiation-free and office-based system ever enabling to scan the WHO references sites and replacing the gold standard radiation-based technology.
Echolight will make osteoporosis diagnosis more accurate, easier accessible and less expensive, reducing the burden of disease on the public healthcare system due to the prevention, early diagnosis and more frequent monitoring of Osteoporosis.
For further information download the teaser at this link.